Info@ThinkPinkRocks.com

Study shows promise for cord blood-derived natural killer cells in multiple myeloma patients

A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient’s own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.

View article:
Study shows promise for cord blood-derived natural killer cells in multiple myeloma patients

Share

Leave a Reply

Solve : *
4 + 27 =